Expergen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.40 M
as on 18-12-2024
- Paid Up Capital ₹ 0.80 M
as on 18-12-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Revenue 9.16%
(FY 2017)
- Profit 29.46%
(FY 2017)
- Ebitda -9.83%
(FY 2017)
- Net Worth
- Total Assets
About Expergen Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.40 M and a paid-up capital of Rs 0.80 M, as per Ministry of Corporate Affairs (MCA) records.
Rupa Sayiour and Pooja Kumari serve as directors at the Company.
- CIN/LLPIN
U74120MH2011PTC213351
- Company No.
213351
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2011
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Expergen Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupa Sayiour  | Director | 01-Apr-2013 | Current |
| Pooja Kumari | Director | 13-May-2024 | Current |
Financial Performance of Expergen Pharmaceuticals.
Expergen Pharmaceuticals Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 9.16% increase. The company also saw a substantial improvement in profitability, with a 29.46% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Expergen Pharmaceuticals?
In 2017, Expergen Pharmaceuticals had a promoter holding of 12.50% and a public holding of 87.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Expergen Pharmaceuticals?
Unlock and access historical data on people associated with Expergen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Expergen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Expergen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
